{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T14:14:49Z","timestamp":1794838489249,"version":"4.9.1"},"reference-count":152,"publisher":"Oxford University Press (OUP)","issue":"27","license":[{"start":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T00:00:00Z","timestamp":1651622400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"CRC1525","award":["453989101"],"award-info":[{"award-number":["453989101"]}]},{"name":"DFG","award":["KFO311"],"award-info":[{"award-number":["KFO311"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,7,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Most patients survive acute myocardial infarction (MI). Yet this encouraging development has certain drawbacks: heart failure (HF) prevalence is increasing and patients affected tend to have more comorbidities worsening economic strain on healthcare systems and impeding effective medical management. The heart\u2019s pathological changes in structure and\/or function, termed myocardial remodelling, significantly impact on patient outcomes. Risk factors like diabetes, chronic obstructive pulmonary disease, female sex, and others distinctly shape disease progression on the \u2018road to HF\u2019. Despite the availability of HF drugs that interact with general pathways involved in myocardial remodelling, targeted drugs remain absent, and patient risk stratification is poor. Hence, in this review, we highlight the pathophysiological basis, current diagnostic methods and available treatments for cardiac remodelling following MI. We further aim to provide a roadmap for developing improved risk stratification and novel medical and interventional therapies.<\/jats:p>","DOI":"10.1093\/eurheartj\/ehac223","type":"journal-article","created":{"date-parts":[[2022,4,15]],"date-time":"2022-04-15T00:00:24Z","timestamp":1649980824000},"page":"2549-2561","source":"Crossref","is-referenced-by-count":641,"title":["Left ventricular remodelling post-myocardial infarction: pathophysiology, imaging, and novel therapies"],"prefix":"10.1093","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0301-6185","authenticated-orcid":false,"given":"Stefan","family":"Frantz","sequence":"first","affiliation":[{"name":"Department of Internal Medicine I, Universit\u00e4tsklinikum W\u00fcrzburg, University Hospital W\u00fcrzburg, University of W\u00fcrzburg , Oberd\u00fcrrbacher Str. 6, 97080 W\u00fcrzburg , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moritz Jens","family":"Hundertmark","sequence":"additional","affiliation":[{"name":"Oxford Centre for Clinical Magnetic Resonance Research (OCMR), Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, John Radcliffe Hospital , Oxford , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanette","family":"Schulz-Menger","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Nephrology, Experimental and Clinical Research Center, a Joint Cooperation between the Charit\u00e9 Medical Faculty and the Max-Delbrueck Center for Molecular Medicine and HELIOS Hospital Berlin Buch , Berlin , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4529-7963","authenticated-orcid":false,"given":"Frank Michael","family":"Bengel","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Hannover Medical School , Hannover , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9341-117X","authenticated-orcid":false,"given":"Johann","family":"Bauersachs","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Angiology, Hannover Medical School , Hannover , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,5,4]]},"reference":[{"key":"2022071323570990100_ehac223-B1","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1161\/01.CIR.0000036014.90197.FA","article-title":"Left ventricular remodeling after primary coronary angioplasty: patterns of left ventricular dilation and long-term prognostic implications","volume":"106","author":"Bolognese","year":"2002","journal-title":"Circulation"},{"key":"2022071323570990100_ehac223-B2","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1161\/CIR.0000000000000757","article-title":"Heart disease and stroke statistics-2020 update: a report from the American Heart Association","volume":"141","author":"Virani","year":"2020","journal-title":"Circulation"},{"key":"2022071323570990100_ehac223-B3","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0140-6736(17)32520-5","article-title":"Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals","volume":"391","author":"Conrad","year":"2018","journal-title":"Lancet"},{"key":"2022071323570990100_ehac223-B4","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.ejheart.2008.09.008","article-title":"Pharmacotherapy according to treatment guidelines is associated with lower mortality in a community-based sample of patients with chronic heart failure: a prospective cohort study","volume":"10","author":"Stork","year":"2008","journal-title":"Eur J Heart Fail"},{"key":"2022071323570990100_ehac223-B5","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ijcard.2017.05.086","article-title":"Risk and predictors of readmission for heart failure following a myocardial infarction between 2004 and 2013: a Swedish nationwide observational study","volume":"248","author":"Desta","year":"2017","journal-title":"Int J Cardiol"},{"key":"2022071323570990100_ehac223-B6","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1056\/NEJM199311113292002","article-title":"Age-related increase in mortality among patients with first myocardial infarctions treated with thrombolysis. The Investigators of the Gruppo Italiano per lo Studio della Sopravvivenza nell\u2019Infarto Miocardico (GISSI-2)","volume":"329","author":"Maggioni","year":"1993","journal-title":"N Engl J Med"},{"key":"2022071323570990100_ehac223-B7","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.jacc.2008.01.011","article-title":"Aging-related defects are associated with adverse cardiac remodeling in a mouse model of reperfused myocardial infarction","volume":"51","author":"Bujak","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"2022071323570990100_ehac223-B8","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.1093\/eurheartj\/ehz835","article-title":"Sex differences in heart failure","volume":"40","author":"Lam","year":"2019","journal-title":"Eur Heart J"},{"key":"2022071323570990100_ehac223-B9","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0002-9149(74)90089-7","article-title":"Role of diabetes in congestive heart failure: the Framingham study","volume":"34","author":"Kannel","year":"1974","journal-title":"Am J Cardiol"},{"key":"2022071323570990100_ehac223-B10","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ajog.2019.04.023","article-title":"Fat mass changes during menopause: a metaanalysis","volume":"221","author":"Ambikairajah","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"2022071323570990100_ehac223-B11","doi-asserted-by":"crossref","first-page":"e017822","DOI":"10.1161\/JAHA.120.017822","article-title":"Trajectories of left ventricular ejection fraction after acute decompensation for systolic heart failure: concomitant echocardiographic and systemic changes, predictors, and impact on clinical outcomes","volume":"10","author":"Albert","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"2022071323570990100_ehac223-B12","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1016\/S0140-6736(14)60107-0","article-title":"Cardiovascular remodelling in coronary artery disease and heart failure","volume":"383","author":"Heusch","year":"2014","journal-title":"Lancet"},{"key":"2022071323570990100_ehac223-B13","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1097\/HJR.0b013e32833158a2","article-title":"Pathological and physiological hypertrophies are regulated by distinct gene programs","volume":"16","author":"Beisvag","year":"2009","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"2022071323570990100_ehac223-B14","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1161\/CIRCULATIONAHA.110.942268","article-title":"Molecular pathways underlying cardiac remodeling during pathophysiological stimulation","volume":"122","author":"Kehat","year":"2010","journal-title":"Circulation"},{"key":"2022071323570990100_ehac223-B15","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1093\/eurheartj\/ehx353","article-title":"Reappraising myocardial fibrosis in severe aortic stenosis: an invasive and non-invasive study in 133 patients","volume":"39","author":"Treibel","year":"2018","journal-title":"Eur Heart J"},{"key":"2022071323570990100_ehac223-B16","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1016\/j.jacc.2020.03.020","article-title":"Extracellular matrix in ischemic heart disease, part 4\/4: JACC Focus Seminar","volume":"75","author":"Frangogiannis","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2022071323570990100_ehac223-B17","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1126\/science.1200708","article-title":"Transient regenerative potential of the neonatal mouse heart","volume":"331","author":"Porrello","year":"2011","journal-title":"Science"},{"key":"2022071323570990100_ehac223-B18","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1161\/CIRCULATIONAHA.119.044619","article-title":"Apical resection prolongs the cell cycle activity and promotes myocardial regeneration after left ventricular injury in neonatal pig","volume":"142","author":"Zhao","year":"2020","journal-title":"Circulation"},{"key":"2022071323570990100_ehac223-B19","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1016\/j.jacc.2021.09.019","article-title":"Basic and translational research in cardiac repair and regeneration: JACC State-of-the-Art Review","volume":"78","author":"Zhang","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"2022071323570990100_ehac223-B20","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/s41577-018-0065-8","article-title":"Cardioimmunology: the immune system in cardiac homeostasis and disease","volume":"18","author":"Swirski","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"2022071323570990100_ehac223-B21","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/ejhf.1138","article-title":"The innate immune system in chronic cardiomyopathy: a European Society of Cardiology (ESC) scientific statement from the Working Group on Myocardial Function of the ESC","volume":"20","author":"Frantz","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"2022071323570990100_ehac223-B22","doi-asserted-by":"crossref","first-page":"e66808","DOI":"10.7554\/eLife.66808","article-title":"Expansion of CD10(neg) neutrophils and CD14(+)HLA-DR(neg\/low) monocytes driving proinflammatory responses in patients with acute myocardial infarction","volume":"10","author":"Fraccarollo","year":"2021","journal-title":"Elife"},{"key":"2022071323570990100_ehac223-B23","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1161\/HYPERTENSIONAHA.118.12162","article-title":"Macrophage mineralocorticoid receptor is a pleiotropic modulator of myocardial infarct healing","volume":"73","author":"Fraccarollo","year":"2019","journal-title":"Hypertension"},{"key":"2022071323570990100_ehac223-B24","doi-asserted-by":"crossref","first-page":"4922","DOI":"10.1172\/JCI123859","article-title":"Myocardial infarction triggers cardioprotective antigen-specific T helper cell responses","volume":"129","author":"Rieckmann","year":"2019","journal-title":"J Clin Invest"},{"key":"2022071323570990100_ehac223-B25","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41569-019-0315-x","article-title":"Reappraising the role of inflammation in heart failure","volume":"17","author":"Adamo","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"2022071323570990100_ehac223-B26","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s41569-020-0403-y","article-title":"Myocardial ischaemia-reperfusion injury and cardioprotection in perspective","volume":"17","author":"Heusch","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"2022071323570990100_ehac223-B27","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nature13909","article-title":"Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS","volume":"515","author":"Chouchani","year":"2014","journal-title":"Nature"},{"key":"2022071323570990100_ehac223-B28","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/cvr\/cvn280","article-title":"Mitochondrial oxidative stress and dysfunction in myocardial remodelling","volume":"81","author":"Tsutsui","year":"2009","journal-title":"Cardiovasc Res"},{"key":"2022071323570990100_ehac223-B29","doi-asserted-by":"crossref","first-page":"H597","DOI":"10.1152\/ajpheart.00731.2016","article-title":"Metabolic remodeling in hypertrophied and failing myocardium: a review","volume":"313","author":"Peterzan","year":"2017","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2022071323570990100_ehac223-B30","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1161\/01.HYP.0000144292.69599.0c","article-title":"Mechanisms for increased glycolysis in the hypertrophied rat heart","volume":"44","author":"Nascimben","year":"2004","journal-title":"Hypertension"},{"key":"2022071323570990100_ehac223-B31","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1093\/cvr\/26.12.1172","article-title":"Developmental changes in energy substrate use by the heart","volume":"26","author":"Lopaschuk","year":"1992","journal-title":"Cardiovasc Res"},{"key":"2022071323570990100_ehac223-B32","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1161\/hc4901.100526","article-title":"Metabolic gene expression in fetal and failing human heart","volume":"104","author":"Razeghi","year":"2001","journal-title":"Circulation"},{"key":"2022071323570990100_ehac223-B33","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0008-6363(01)00393-5","article-title":"Postinfarction heart failure in rats is associated with upregulation of GLUT-1 and downregulation of genes of fatty acid metabolism","volume":"52","author":"Rosenblatt-Velin","year":"2001","journal-title":"Cardiovasc Res"},{"key":"2022071323570990100_ehac223-B34","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1161\/CIRCRESAHA.118.312017","article-title":"Metabolic coordination of physiological and pathological cardiac remodeling","volume":"123","author":"Gibb","year":"2018","journal-title":"Circ Res"},{"key":"2022071323570990100_ehac223-B35","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.yjmcc.2016.09.001","article-title":"Preservation of myocardial fatty acid oxidation prevents diastolic dysfunction in mice subjected to angiotensin II infusion","volume":"100","author":"Choi","year":"2016","journal-title":"J Mol Cell Cardiol"},{"key":"2022071323570990100_ehac223-B36","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1161\/CIRCRESAHA.112.268128","article-title":"Cardiac-specific deletion of acetyl CoA carboxylase 2 prevents metabolic remodeling during pressure-overload hypertrophy","volume":"111","author":"Kolwicz SC","year":"2012","journal-title":"Circ Res"},{"key":"2022071323570990100_ehac223-B37","doi-asserted-by":"crossref","first-page":"C817","DOI":"10.1152\/ajpcell.00139.2004","article-title":"Calcium, ATP, and ROS: a mitochondrial love-hate triangle","volume":"287","author":"Brookes","year":"2004","journal-title":"Am J Physiol Cell Physiol"},{"key":"2022071323570990100_ehac223-B38","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0008-6363(98)00099-6","article-title":"Beta-adrenergic signal transduction following carvedilol treatment in hypertensive cardiac hypertrophy","volume":"40","author":"Bohm","year":"1998","journal-title":"Cardiovasc Res"},{"key":"2022071323570990100_ehac223-B39","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1161\/01.RES.68.3.856","article-title":"Cellular basis of chronic ventricular remodeling after myocardial infarction in rats","volume":"68","author":"Olivetti","year":"1991","journal-title":"Circ Res"},{"key":"2022071323570990100_ehac223-B40","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/j.jacc.2009.02.030","article-title":"Combined increased chemosensitivity to hypoxia and hypercapnia as a prognosticator in heart failure","volume":"53","author":"Giannoni","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2022071323570990100_ehac223-B41","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1056\/NEJM198409273111303","article-title":"Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure","volume":"311","author":"Cohn","year":"1984","journal-title":"N Engl J Med"},{"key":"2022071323570990100_ehac223-B42","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1161\/01.CIR.82.5.1724","article-title":"Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD)","volume":"82","author":"Francis","year":"1990","journal-title":"Circulation"},{"key":"2022071323570990100_ehac223-B43","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"2022071323570990100_ehac223-B44","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1146\/annurev-physiol-031620-093431","article-title":"Renal denervation to treat heart failure","volume":"83","author":"Sharp","year":"2021","journal-title":"Annu Rev Physiol"},{"key":"2022071323570990100_ehac223-B45","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1161\/CIRCULATIONAHA.117.028814","article-title":"Cardiorenal syndrome revisited","volume":"138","author":"Zannad","year":"2018","journal-title":"Circulation"},{"key":"2022071323570990100_ehac223-B46","first-page":"S321","article-title":"Human atrial natriuretic polypeptides (hANP): purification, structure synthesis and biological activity","volume":"2","author":"Kangawa","year":"1984","journal-title":"J Hypertens Suppl"},{"key":"2022071323570990100_ehac223-B47","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1152\/physrev.00022.2015","article-title":"Molecular physiology of membrane guanylyl cyclase receptors","volume":"96","author":"Kuhn","year":"2016","journal-title":"Physiol Rev"},{"key":"2022071323570990100_ehac223-B48","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1093\/eurheartj\/ehn206","article-title":"Effect of atrial natriuretic peptide on left ventricular remodelling in patients with acute myocardial infarction","volume":"29","author":"Kasama","year":"2008","journal-title":"Eur Heart J"},{"key":"2022071323570990100_ehac223-B49","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.cardfail.2003.08.011","article-title":"Subcutaneous administration of the cardiac hormone BNP in symptomatic human heart failure","volume":"10","author":"Chen","year":"2004","journal-title":"J Card Fail"},{"key":"2022071323570990100_ehac223-B50","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1136\/hrt.2003.018325","article-title":"Natriuretic peptides as a prognostic marker and therapeutic target in heart failure","volume":"92","author":"Wright","year":"2006","journal-title":"Heart"},{"key":"2022071323570990100_ehac223-B51","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/s41569-020-0381-0","article-title":"Cardiac natriuretic peptides","volume":"17","author":"Goetze","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"2022071323570990100_ehac223-B52","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1373\/clinchem.2016.262907","article-title":"Biochemistry, therapeutics, and biomarker implications of neprilysin in cardiorenal disease","volume":"63","author":"Chen","year":"2017","journal-title":"Clin Chem"},{"key":"2022071323570990100_ehac223-B53","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1161\/01.HYP.35.1.19","article-title":"Inhibitory regulation of hypertrophy by endogenous atrial natriuretic peptide in cultured cardiac myocytes","volume":"35","author":"Horio","year":"2000","journal-title":"Hypertension"},{"key":"2022071323570990100_ehac223-B54","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1038\/sj.bjp.0703679","article-title":"Effect of neutral endopeptidase inhibitor on endogenous atrial natriuretic peptide as a paracrine factor in cultured cardiac fibroblasts","volume":"131","author":"Maki","year":"2000","journal-title":"Br J Pharmacol"},{"key":"2022071323570990100_ehac223-B55","doi-asserted-by":"crossref","first-page":"15902","DOI":"10.1038\/s41598-020-72710-3","article-title":"The clinical effect of recombinant human brain natriuretic peptide on asymptomatic peri-procedural myocardial injury after percutaneous transluminal coronary angioplasty","volume":"10","author":"Liang","year":"2020","journal-title":"Sci Rep"},{"key":"2022071323570990100_ehac223-B56","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1093\/ehjci\/jex244","article-title":"Standardization of adult transthoracic echocardiography reporting in agreement with recent chamber quantification, diastolic function, and heart valve disease recommendations: an expert consensus document of the European Association of Cardiovascular Imaging","volume":"18","author":"Galderisi","year":"2017","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2022071323570990100_ehac223-B57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"28","author":"Lang","year":"2015","journal-title":"J Am Soc Echocardiogr"},{"key":"2022071323570990100_ehac223-B58","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1093\/eurheartj\/ehi083","article-title":"Assessment of systolic left ventricular function: a multi-centre comparison of cineventriculography, cardiac magnetic resonance imaging, unenhanced and contrast-enhanced echocardiography","volume":"26","author":"Hoffmann","year":"2005","journal-title":"Eur Heart J"},{"key":"2022071323570990100_ehac223-B59","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ahj.2011.03.031","article-title":"Phase II trials in heart failure: the role of cardiovascular imaging","volume":"162","author":"Shah","year":"2011","journal-title":"Am Heart J"},{"key":"2022071323570990100_ehac223-B60","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/ehjci\/jet038","article-title":"Image-guided therapies for myocardial repair: concepts and practical implementation","volume":"14","author":"Bengel","year":"2013","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2022071323570990100_ehac223-B61","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.amjcard.2012.02.069","article-title":"Usefulness of circulating biomarkers for the prediction of left ventricular remodeling after myocardial infarction","volume":"110","author":"Fertin","year":"2012","journal-title":"Am J Cardiol"},{"key":"2022071323570990100_ehac223-B62","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/eurheartj\/ehx402","article-title":"Refining the prognostic impact of functional mitral regurgitation in chronic heart failure","volume":"39","author":"Goliasch","year":"2018","journal-title":"Eur Heart J"},{"key":"2022071323570990100_ehac223-B63","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1093\/eurheartj\/ehx243","article-title":"The future of cardiovascular magnetic resonance imaging","volume":"38","author":"Friedrich","year":"2017","journal-title":"Eur Heart J"},{"key":"2022071323570990100_ehac223-B64","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/ehf2.12576","article-title":"Comparison of feature tracking, fast-SENC, and myocardial tagging for global and segmental left ventricular strain","volume":"7","author":"Bucius","year":"2020","journal-title":"ESC Heart Fail"},{"key":"2022071323570990100_ehac223-B65","doi-asserted-by":"crossref","first-page":"3962","DOI":"10.1007\/s00330-020-07539-5","article-title":"Quantification of myocardial strain assessed by cardiovascular magnetic resonance feature tracking in healthy subjects-influence of segmentation and analysis software","volume":"31","author":"Lim","year":"2021","journal-title":"Eur Radiol"},{"key":"2022071323570990100_ehac223-B66","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/ejhf.2402","article-title":"Prognostic value of cardiac magnetic resonance parameters and biomarkers following myocardial infarction; 10-year follow-up of the Eplerenone Remodelling in Myocardial Infarction without Heart Failure trial","volume":"24","author":"Weir","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"2022071323570990100_ehac223-B67","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s10554-019-01726-2","article-title":"Impact of posteromedial papillary muscle infarction on mitral regurgitation during ST-segment elevation myocardial infarction","volume":"36","author":"Klug","year":"2020","journal-title":"Int J Cardiovasc Imaging"},{"key":"2022071323570990100_ehac223-B68","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1161\/CIRCIMAGING.113.000411","article-title":"Prognostic relevance of papillary muscle infarction in reperfused infarction as visualized by cardiovascular magnetic resonance","volume":"6","author":"Eitel","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"2022071323570990100_ehac223-B69","first-page":"143","article-title":"ESC working group position paper on myocardial infarction with non-obstructive coronary arteries","volume":"38","author":"Agewall","year":"2017","journal-title":"Eur Heart J"},{"key":"2022071323570990100_ehac223-B70","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.jcmg.2016.11.010","article-title":"Myocardial infarction with nonobstructed coronary arteries: impact of CMR early after presentation","volume":"10","author":"Dastidar","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"key":"2022071323570990100_ehac223-B71","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1093\/ehjci\/jev289","article-title":"Troponin-positive chest pain with unobstructed coronary arteries: incremental diagnostic value of cardiovascular magnetic resonance imaging","volume":"17","author":"Pathik","year":"2016","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2022071323570990100_ehac223-B72","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1007\/s00330-018-5895-z","article-title":"Microvascular obstruction extent predicts major adverse cardiovascular events in patients with acute myocardial infarction and preserved ejection fraction","volume":"29","author":"Galea","year":"2019","journal-title":"Eur Radiol"},{"key":"2022071323570990100_ehac223-B73","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.jacc.2017.12.020","article-title":"Native T1 and ECV of noninfarcted myocardium and outcome in patients with coronary artery disease","volume":"71","author":"Puntmann","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2022071323570990100_ehac223-B74","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12968-017-0389-8","article-title":"Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: a consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI)","volume":"19","author":"Messroghli","year":"2017","journal-title":"J Cardiovasc Magn Reson"},{"key":"2022071323570990100_ehac223-B75","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jacc.2021.10.034","article-title":"Intramyocardial hemorrhage and the \u201cWave Front\u201d of reperfusion injury compromising myocardial salvage","volume":"79","author":"Liu","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"2022071323570990100_ehac223-B76","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.jcmg.2014.06.012","article-title":"Effect of microvascular obstruction and intramyocardial hemorrhage by CMR on LV remodeling and outcomes after myocardial infarction: a systematic review and meta-analysis","volume":"7","author":"Hamirani","year":"2014","journal-title":"JACC Cardiovasc Imaging"},{"key":"2022071323570990100_ehac223-B77","doi-asserted-by":"crossref","first-page":"8956","DOI":"10.1007\/s00330-021-08032-3","article-title":"Increased oxygenation is associated with myocardial inflammation and adverse regional remodeling after acute ST-segment elevation myocardial infarction","volume":"31","author":"Shi","year":"2021","journal-title":"Eur Radiol"},{"key":"2022071323570990100_ehac223-B78","doi-asserted-by":"crossref","first-page":"951","DOI":"10.2967\/jnumed.119.240440","article-title":"The changing face of nuclear cardiology: guiding cardiovascular care toward molecular medicine","volume":"61","author":"Werner","year":"2020","journal-title":"J Nucl Med"},{"key":"2022071323570990100_ehac223-B79","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1161\/CIRCULATIONAHA.118.036459","article-title":"Cardiovascular effects of treatment with the ketone body 3-hydroxybutyrate in chronic heart failure patients","volume":"139","author":"Nielsen","year":"2019","journal-title":"Circulation"},{"key":"2022071323570990100_ehac223-B80","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1161\/01.CIR.0000127959.28627.F8","article-title":"Effect of obesity and insulin resistance on myocardial substrate metabolism and efficiency in young women","volume":"109","author":"Peterson","year":"2004","journal-title":"Circulation"},{"key":"2022071323570990100_ehac223-B81","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1161\/CIRCULATIONAHA.108.778019","article-title":"Trimetazidine, a metabolic modulator, has cardiac and extracardiac benefits in idiopathic dilated cardiomyopathy","volume":"118","author":"Tuunanen","year":"2008","journal-title":"Circulation"},{"key":"2022071323570990100_ehac223-B82","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jacc.2013.07.096","article-title":"Regional myocardial sympathetic denervation predicts the risk of sudden cardiac arrest in ischemic cardiomyopathy","volume":"63","author":"Fallavollita","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2022071323570990100_ehac223-B83","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/j.jacc.2010.01.014","article-title":"Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study","volume":"55","author":"Jacobson","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2022071323570990100_ehac223-B84","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.ehj.2004.02.016","article-title":"Presence of sympathetically denervated but viable myocardium and its electrophysiologic correlates after early revascularised, acute myocardial infarction","volume":"25","author":"Simoes","year":"2004","journal-title":"Eur Heart J"},{"key":"2022071323570990100_ehac223-B85","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/j.jcmg.2015.09.008","article-title":"Molecular imaging of the chemokine receptor CXCR4 after acute myocardial infarction","volume":"8","author":"Thackeray","year":"2015","journal-title":"JACC Cardiovasc Imaging"},{"key":"2022071323570990100_ehac223-B86","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1161\/CIRCRESAHA.118.314030","article-title":"Molecular imaging visualizes recruitment of inflammatory monocytes and macrophages to the injured heart","volume":"124","author":"Heo","year":"2019","journal-title":"Circ Res"},{"key":"2022071323570990100_ehac223-B87","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1016\/j.jacc.2019.02.052","article-title":"68Ga-DOTATATE PET identifies residual myocardial inflammation and bone marrow activation after myocardial infarction","volume":"73","author":"Tarkin","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2022071323570990100_ehac223-B88","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jacc.2017.11.024","article-title":"Myocardial inflammation predicts remodeling and neuroinflammation after myocardial infarction","volume":"71","author":"Thackeray","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2022071323570990100_ehac223-B89","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.jcmg.2018.05.026","article-title":"Molecular imaging of myocardial inflammation with positron emission tomography post-ischemia: a determinant of subsequent remodeling or recovery","volume":"11","author":"Thackeray","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"key":"2022071323570990100_ehac223-B90","doi-asserted-by":"crossref","first-page":"e009055","DOI":"10.1161\/CIRCIMAGING.119.009055","article-title":"Application of hybrid matrix metalloproteinase-targeted and dynamic (201)Tl single-photon emission computed tomography\/computed tomography imaging for evaluation of early post-myocardial infarction remodeling","volume":"12","author":"Thorn","year":"2019","journal-title":"Circ Cardiovasc Imaging"},{"key":"2022071323570990100_ehac223-B91","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/j.jacc.2021.02.019","article-title":"Molecular imaging identifies fibroblast activation beyond the infarct region after acute myocardial infarction","volume":"77","author":"Diekmann","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"2022071323570990100_ehac223-B92","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.nucmedbio.2021.09.001","article-title":"Novel O-[(11)C]-methylated derivatives of the neprilysin inhibitor sacubitril: Radiosynthesis, autoradiography and plasma stability evaluation","volume":"102\u2013103","author":"Teyssier","year":"2021","journal-title":"Nucl Med Biol"},{"key":"2022071323570990100_ehac223-B93","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.3390\/pharmaceutics13071097","article-title":"Simplified (89)Zr-labeling protocol of oxine (8-Hydroxyquinoline) Enabling prolonged tracking of liposome-based nanomedicines and cells","volume":"13","author":"Polyak","year":"2021","journal-title":"Pharmaceutics"},{"key":"2022071323570990100_ehac223-B94","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.1093\/eurheartj\/ehaa598","article-title":"Molecular imaging-guided repair after acute myocardial infarction by targeting the chemokine receptor CXCR4","volume":"41","author":"Hess","year":"2020","journal-title":"Eur Heart J"},{"key":"2022071323570990100_ehac223-B95","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jcmg.2021.08.013","article-title":"CXCR4-targeted imaging of post-infarct myocardial tissue inflammation: prognostic value after reperfused myocardial infarction","volume":"15","author":"Werner","year":"2022","journal-title":"JACC Cardiovasc Imaging"},{"key":"2022071323570990100_ehac223-B96","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.jcmg.2018.01.001","article-title":"Imaging of C-X-C motif chemokine receptor CXCR4 expression after myocardial infarction with [(68)Ga]Pentixafor-PET\/CT in correlation with cardiac MRI","volume":"11","author":"Reiter","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"key":"2022071323570990100_ehac223-B97","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1016\/j.jcmg.2019.11.007","article-title":"Radionuclide image-guided repair of the heart","volume":"13","author":"Hess","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"2022071323570990100_ehac223-B98","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/j.jacc.2015.02.034","article-title":"Imaging systemic inflammatory networks in ischemic heart disease","volume":"65","author":"Nahrendorf","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2022071323570990100_ehac223-B99","doi-asserted-by":"crossref","first-page":"977","DOI":"10.2967\/jnumed.119.236885","article-title":"11C-Methionine PET identifies astroglia involvement in heart-brain Inflammation networking after acute myocardial infarction","volume":"61","author":"Bascunana","year":"2020","journal-title":"J Nucl Med"},{"key":"2022071323570990100_ehac223-B100","doi-asserted-by":"crossref","first-page":"7984","DOI":"10.7150\/thno.61423","article-title":"Molecular imaging of inflammation crosstalk along the cardio-renal axis following acute myocardial infarction","volume":"11","author":"Werner","year":"2021","journal-title":"Theranostics"},{"key":"2022071323570990100_ehac223-B101","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1161\/01.RES.57.1.84","article-title":"Influence of chronic captopril therapy on the infarcted left ventricle of the rat","volume":"57","author":"Pfeffer","year":"1985","journal-title":"Circ Res"},{"key":"2022071323570990100_ehac223-B102","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJM199209033271001","article-title":"Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators","volume":"327","author":"Pfeffer","year":"1992","journal-title":"N Engl J Med"},{"key":"2022071323570990100_ehac223-B103","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1056\/NEJMoa032292","article-title":"Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both","volume":"349","author":"Pfeffer","year":"2003","journal-title":"N Engl J Med"},{"key":"2022071323570990100_ehac223-B104","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1016\/j.jacc.2003.05.003","article-title":"Additive improvement of left ventricular remodeling and neurohormonal activation by aldosterone receptor blockade with eplerenone and ACE inhibition in rats with myocardial infarction","volume":"42","author":"Fraccarollo","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"2022071323570990100_ehac223-B105","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"key":"2022071323570990100_ehac223-B106","doi-asserted-by":"crossref","first-page":"4425","DOI":"10.1093\/eurheartj\/ehaa733","article-title":"Metoprolol exerts a non-class effect against ischaemia-reperfusion injury by abrogating exacerbated inflammation","volume":"41","author":"Clemente-Moragon","year":"2020","journal-title":"Eur Heart J"},{"key":"2022071323570990100_ehac223-B107","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1056\/NEJMoa1409077","article-title":"Neprilysin inhibition for heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N Engl J Med"},{"key":"2022071323570990100_ehac223-B108","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1161\/CIRCULATIONAHA.121.054892","article-title":"Effect of neprilysin inhibition on left ventricular remodeling in patients with asymptomatic left ventricular systolic dysfunction late after myocardial infarction","volume":"144","author":"Docherty","year":"2021","journal-title":"Circulation"},{"key":"2022071323570990100_ehac223-B109","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1002\/ejhf.2191","article-title":"Prospective ARNI vs. ACE inhibitor trial to DetermIne Superiority in reducing heart failure Events after Myocardial Infarction (PARADISE-MI): design and baseline characteristics","volume":"23","author":"Jering","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"2022071323570990100_ehac223-B110","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1001\/jama.2019.12821","article-title":"Association of change in N-terminal Pro-B-type natriuretic peptide following initiation of sacubitril-valsartan treatment with cardiac structure and function in patients with heart failure with reduced ejection fraction","volume":"322","author":"Januzzi JL","year":"2019","journal-title":"JAMA"},{"key":"2022071323570990100_ehac223-B111","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1056\/NEJMoa2104508","article-title":"Angiotensin receptor-neprilysin inhibition in acute myocardial infarction","volume":"385","author":"Pfeffer","year":"2021","journal-title":"N Engl J Med"},{"key":"2022071323570990100_ehac223-B112","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1161\/CIRCULATIONAHA.121.057429","article-title":"Impact of sacubitril\/valsartan versus ramipril on total heart failure events in the PARADISE-MI Trial","volume":"145","author":"Pfeffer","year":"2022","journal-title":"Circulation"},{"key":"2022071323570990100_ehac223-B113","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in heart failure with a preserved ejection fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N Engl J Med"},{"key":"2022071323570990100_ehac223-B114","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N Engl J Med"},{"key":"2022071323570990100_ehac223-B115","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","article-title":"Cardiovascular and renal outcomes with empagliflozin in heart failure","volume":"383","author":"Packer","year":"2020","journal-title":"N Engl J Med"},{"key":"2022071323570990100_ehac223-B116","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1161\/CIRCULATIONAHA.120.052186","article-title":"Effect of empagliflozin on left ventricular volumes in patients with type 2 diabetes, or prediabetes, and heart failure with reduced ejection fraction (SUGAR-DM-HF)","volume":"143","author":"Lee","year":"2021","journal-title":"Circulation"},{"key":"2022071323570990100_ehac223-B117","doi-asserted-by":"crossref","first-page":"A674","DOI":"10.1016\/S0735-1097(18)31215-4","article-title":"Empagliflozin induces a myocardial metabolic shift from glucose consumption to ketone metabolism that mitigates adverse cardiac remodeling and improves myocardial contractility","volume":"71","author":"Santos-Gallego","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2022071323570990100_ehac223-B118","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1161\/01.RES.86.5.580","article-title":"The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase","volume":"86","author":"Kantor","year":"2000","journal-title":"Cir Res"},{"key":"2022071323570990100_ehac223-B119","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.ehj.2004.02.018","article-title":"Metabolic manipulation in ischaemic heart disease, a novel approach to treatment","volume":"25","author":"Lee","year":"2004","journal-title":"Eur Heart J"},{"key":"2022071323570990100_ehac223-B120","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1186\/s12872-020-01557-3","article-title":"Effects of trimetazidine on ventricular remodeling in coronary artery disease patients with left ventricular hypertrophy: the rationale and design of a randomized controlled trial","volume":"20","author":"Wu","year":"2020","journal-title":"BMC Cardiovasc Disord"},{"key":"2022071323570990100_ehac223-B121","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1161\/hc3401.095946","article-title":"Improvement of left ventricular remodeling and function by hydroxymethylglutaryl coenzyme a reductase inhibition with cerivastatin in rats with heart failure after myocardial infarction","volume":"104","author":"Bauersachs","year":"2001","journal-title":"Circulation"},{"key":"2022071323570990100_ehac223-B122","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/S0735-1097(02)02375-6","article-title":"Impact of hydroxymethylglutaryl coenzyme a reductase inhibition on left ventricular remodeling after myocardial infarction: an experimental serial cardiac magnetic resonance imaging study","volume":"40","author":"Nahrendorf","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"2022071323570990100_ehac223-B123","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1038\/nature07511","article-title":"MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts","volume":"456","author":"Thum","year":"2008","journal-title":"Nature"},{"key":"2022071323570990100_ehac223-B124","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1161\/CIRCRESAHA.113.300226","article-title":"Non-coding RNAs in cardiac remodeling and heart failure","volume":"113","author":"Kumarswamy","year":"2013","journal-title":"Circ Res"},{"key":"2022071323570990100_ehac223-B125","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/s41467-020-14349-2","article-title":"Preclinical development of a miR-132 inhibitor for heart failure treatment","volume":"11","author":"Foinquinos","year":"2020","journal-title":"Nat Commun"},{"key":"2022071323570990100_ehac223-B126","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/eurheartj\/ehaa791","article-title":"CDR132L improves systolic and diastolic function in a large animal model of chronic heart failure","volume":"42","author":"Batkai","year":"2021","journal-title":"Eur Heart J"},{"key":"2022071323570990100_ehac223-B127","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/eurheartj\/ehaa898","article-title":"Novel antisense therapy targeting microRNA-132 in patients with heart failure: results of a first-in-human Phase 1b randomized, double-blind, placebo-controlled study","volume":"42","author":"Taubel","year":"2021","journal-title":"Eur Heart J"},{"key":"2022071323570990100_ehac223-B128","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1161\/01.CIR.0000124490.27666.B2","article-title":"Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL)","volume":"109","author":"Mann","year":"2004","journal-title":"Circulation"},{"key":"2022071323570990100_ehac223-B129","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"key":"2022071323570990100_ehac223-B130","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1161\/CIRCULATIONAHA.118.038010","article-title":"Anti-Inflammatory therapy with canakinumab for the prevention of hospitalization for heart failure","volume":"139","author":"Everett","year":"2019","journal-title":"Circulation"},{"key":"2022071323570990100_ehac223-B131","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1126\/science.abm0594","article-title":"CAR T cells produced in vivo to treat cardiac injury","volume":"375","author":"Rurik","year":"2022","journal-title":"Science"},{"key":"2022071323570990100_ehac223-B132","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41569-018-0073-1","article-title":"Nanoimmunotherapy to treat ischaemic heart disease","volume":"16","author":"Duivenvoorden","year":"2019","journal-title":"Nat Rev Cardiol"},{"key":"2022071323570990100_ehac223-B133","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.addr.2021.05.004","article-title":"Targeting fibrosis in the failing heart with nanoparticles","volume":"174","author":"Passaro","year":"2021","journal-title":"Adv Drug Deliv Rev"},{"key":"2022071323570990100_ehac223-B134","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1093\/cvr\/cvaa287","article-title":"Angiogenesis after acute myocardial infarction","volume":"117","author":"Wu","year":"2021","journal-title":"Cardiovasc Res"},{"key":"2022071323570990100_ehac223-B135","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/nm.3778","article-title":"Myeloid-derived growth factor (C19orf10) mediates cardiac repair following myocardial infarction","volume":"21","author":"Korf-Klingebiel","year":"2015","journal-title":"Nat Med"},{"key":"2022071323570990100_ehac223-B136","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1161\/CIRCULATIONAHA.117.029980","article-title":"EMC10 (Endoplasmic Reticulum Membrane Protein Complex Subunit 10) is a bone marrow-derived angiogenic growth factor promoting tissue repair after myocardial infarction","volume":"136","author":"Reboll","year":"2017","journal-title":"Circulation"},{"key":"2022071323570990100_ehac223-B137","doi-asserted-by":"crossref","first-page":"103533","DOI":"10.1016\/j.isci.2021.103533","article-title":"Adenoviral VEGF-B186R127S gene transfer induces angiogenesis and improves perfusion in ischemic heart","volume":"24","author":"Korpela","year":"2021","journal-title":"iScience"},{"key":"2022071323570990100_ehac223-B138","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1093\/eurheartj\/ehx352","article-title":"Adenoviral intramyocardial VEGF-DDeltaNDeltaC gene transfer increases myocardial perfusion reserve in refractory angina patients: a phase I\/IIa study with 1-year follow-up","volume":"38","author":"Hartikainen","year":"2017","journal-title":"Eur Heart J"},{"key":"2022071323570990100_ehac223-B139","article-title":"Long-term safety and efficacy of intramyocardial adenovirus-mediated VEGF-D(DeltaNDeltaC) gene therapy eight-year follow-up of phase I KAT301 study","author":"Leikas","year":"2021","journal-title":"Gene Ther"},{"key":"2022071323570990100_ehac223-B140","doi-asserted-by":"crossref","first-page":"e148555","DOI":"10.1172\/JCI148555","article-title":"Moving toward genome-editing therapies for cardiovascular diseases","volume":"132","author":"Musunuru","year":"2022","journal-title":"J Clin Invest"},{"key":"2022071323570990100_ehac223-B141","doi-asserted-by":"crossref","first-page":"3711","DOI":"10.1093\/eurheartj\/ehaa802","article-title":"Cell therapy for acute myocardial infarction: requiescat in pace","volume":"41","author":"Bolli","year":"2020","journal-title":"Eur Heart J"},{"key":"2022071323570990100_ehac223-B142","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.1093\/eurheartj\/ehaa557","article-title":"Cardiovascular regenerative and reparative medicine: is myocardial infarction the model?","volume":"41","author":"Sanz-Ruiz","year":"2020","journal-title":"Eur Heart J"},{"key":"2022071323570990100_ehac223-B143","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1093\/eurheartj\/ehx188","article-title":"Intracoronary autologous bone marrow cell transfer after myocardial infarction: the BOOST-2 randomised placebo-controlled clinical trial","volume":"38","author":"Wollert","year":"2017","journal-title":"Eur Heart J"},{"key":"2022071323570990100_ehac223-B144","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1093\/eurheartj\/ehaa541","article-title":"Intracoronary ALLogeneic heart STem cells to Achieve myocardial Regeneration (ALLSTAR): a randomized, placebo-controlled, double-blinded trial","volume":"41","author":"Makkar","year":"2020","journal-title":"Eur Heart J"},{"key":"2022071323570990100_ehac223-B145","doi-asserted-by":"crossref","first-page":"3702","DOI":"10.1093\/eurheartj\/ehaa651","article-title":"The effect of intracoronary infusion of bone marrow-derived mononuclear cells on all-cause mortality in acute myocardial infarction: the BAMI trial","volume":"41","author":"Mathur","year":"2020","journal-title":"Eur Heart J"},{"key":"2022071323570990100_ehac223-B146","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1002\/ccd.29090","article-title":"One-year outcomes of supersaturated oxygen therapy in acute anterior myocardial infarction: The IC-HOT study","volume":"97","author":"Chen","year":"2021","journal-title":"Catheter Cardiovasc Interv"},{"key":"2022071323570990100_ehac223-B147","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1056\/NEJMoa0900559","article-title":"Coronary bypass surgery with or without surgical ventricular reconstruction","volume":"360","author":"Jones","year":"2009","journal-title":"N Engl J Med"},{"key":"2022071323570990100_ehac223-B148","doi-asserted-by":"crossref","first-page":"183","DOI":"10.21037\/cdt-20-265","article-title":"Hybrid transcatheter left ventricular reconstruction for the treatment of ischemic cardiomyopathy","volume":"11","author":"Biffi","year":"2021","journal-title":"Cardiovasc Diagn Ther"},{"key":"2022071323570990100_ehac223-B149","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ijcard.2012.09.019","article-title":"First-in-man safety evaluation of renal denervation for chronic systolic heart failure: primary outcome from REACH-Pilot study","volume":"162","author":"Davies","year":"2013","journal-title":"Int J Cardiol"},{"key":"2022071323570990100_ehac223-B150","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1016\/j.jacc.2018.08.2186","article-title":"Renal denervation prevents heart failure progression via inhibition of the renin-angiotensin system","volume":"72","author":"Sharp","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2022071323570990100_ehac223-B151","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1161\/HYPERTENSIONAHA.120.16054","article-title":"Renal, cardiac, and autonomic effects of catheter-based renal denervation in ovine heart failure","volume":"78","author":"Booth","year":"2021","journal-title":"Hypertension"},{"key":"2022071323570990100_ehac223-B152","doi-asserted-by":"crossref","first-page":"e007421","DOI":"10.1161\/CIRCHEARTFAILURE.120.007421","article-title":"Renal sympathetic denervation in patients with heart failure with preserved ejection fraction","volume":"14","author":"Kresoja","year":"2021","journal-title":"Circ Heart Fail"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/43\/27\/2549\/44858147\/ehac223.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/43\/27\/2549\/44858147\/ehac223.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T19:58:50Z","timestamp":1657742330000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/43\/27\/2549\/6578707"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,4]]},"references-count":152,"journal-issue":{"issue":"27","published-online":{"date-parts":[[2022,5,4]]},"published-print":{"date-parts":[[2022,7,14]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehac223","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,7,14]]},"published":{"date-parts":[[2022,5,4]]}}}